quantisnow
FeedTopReportsPricing
⌘K
Live feed
14:31:45·2045d
PRRelease
Momenta Pharmaceuticals, Inc. logo
Jefferson Capital Inc. logo
Rosetta Stone logo
+1

Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Rosetta Stone, Momenta, Jernigan, and Varian on behalf of Stockholders and Encourages Investors to Contact the Firm

MNTA· Momenta Pharmaceuticals, Inc.JCAP· Jefferson Capital Inc.RST· Rosetta StoneVAR· Varian Medical Systems, Inc.
Health CareFinanceTechnology
Full content unavailable. See the original source below.
Original source

Companies

  • MNTA
    Momenta Pharmaceuticals, Inc.
    Health Care
  • JCAP
    Jefferson Capital Inc.
    Finance
  • RST
    Rosetta Stone
    Technology
  • VAR
    Varian Medical Systems, Inc.
    Health Care

Recent analyst ratings

  • Jul 21JCAPUpdateCitizens JMP$23.00
  • Jul 21JCAPUpdateKeefe Bruyette$22.00
  • Jul 21JCAPUpdateJefferies$29.00
  • Jul 21JCAPUpdateTruist$24.00
  • Jul 21JCAPUpdateRaymond James$19.00

Related

  • SEC10h
    Jefferson Capital Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
  • PR18h
    Jefferson Capital Secures Credit Facility Expansion
  • SEC2d
    SEC Form DEFA14A filed by Jefferson Capital Inc.
  • SEC2d
    SEC Form DEF 14A filed by Jefferson Capital Inc.
  • INSIDER36d
    SEC Form 4 filed by Zellmann Mark Joseph
  • INSIDER36d
    SEC Form 3 filed by new insider Atkins Susan E.
  • INSIDER36d
    SEC Form 3 filed by new insider Pierce James Manfred
  • SEC36d
    Jefferson Capital Inc. filed SEC Form 8-K: Leadership Update
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022